The Low Carb Diabetic

Promoting a low carb high fat lifestyle for the safe control of diabetes. Eat whole fresh food, more drugs are not the answer.


Welcome to the Low Carb Diabetic forum,have you signed up yet? if not then sign up and join us in the low carb community today!

    Diabetes drug trial needs to widen participants to understand full impact of drugs

    Share
    avatar
    graham64
    Member

    Status :
    Online
    Offline

    Male Posts : 3107
    Join date : 2014-08-10
    Location : Lancs

    Diabetes drug trial needs to widen participants to understand full impact of drugs

    Post by graham64 on Mon Jul 17 2017, 21:55

    More work needs to be done to examine the real world effects of the commonly prescribed diabetes drug empagliflozin, new research in the journal Diabetes Therapy finds.

    Examining data from over 60,000 patients with type 2 diabetes, researchers from the University of Surrey discovered that the highly-publicised cardiovascular benefits of the popular diabetes drug empagliflozin cannot be applied to the vast majority of patients with the illness.

    An international safety trial of empagliflozin, and other drugs in the sodium-glucose co-transporter 2 (SGLT2) inhibitor drug class, made the surprising discovery that these medications positively impact upon the workings of cardiovascular systems, including a decreased risk of heart attacks. Despite being hailed as ground-breaking, limitations of the trial were identified due to its focus on patients identified as high risk of cardiovascular disease.

    Equipped with this knowledge, researchers from the University of Surrey examined the potential impact of this drug on those deemed at lower risk of cardiovascular disease. Researchers found that only 11 per cent of patients with type 2 diabetes who were prescribed empagliflozin were identified as being at as high a risk of cardiovascular disease as those in the trial. They concluded that these patients may not see any cardiovascular improvements from the drug. Similarly, only 16 per cent of patients with type 2 diabetes who were not prescribed the drug were identified as being as high a risk of cardiovascular disease as those in the trial.

    Such findings highlight the limitations of clinical trials which are often only directly applicable to a small proportion of people whom the medications are prescribed for and often leads to misconceptions about the workings of the drug.

    Lead author of the paper, Dr Andy McGovern, from the University of Surrey said: "The benefits of this drug for patients at high risk of cardiovascular disease are clear. However what we have found a major limitation of the clinical trial; it can only be applied to a small proportion of people with type 2 diabetes.

    "Recognising this shortcoming will help clinicians better explain to patients how this drug will benefit them."

    https://medicalxpress.com/news/2017-06-diabetes-drug-trial-widen-full.html


    _________________
    I'm a skinny T2 diagnosed 4/4/2008, a high calorie LCHF diet and one metformin a day A1c 6.2 and no complications.

    Proving the LowCarb sceptics wrong for over nine years,

    Not all cherubs are Angels  Wink nor all diabetics Bonkers  Rolling Eyes
    avatar
    chris c
    Member

    Status :
    Online
    Offline

    Posts : 3419
    Join date : 2015-07-26

    Re: Diabetes drug trial needs to widen participants to understand full impact of drugs

    Post by chris c on Mon Jul 17 2017, 23:24

    Someone described these drugs as "low carb in a pill" because they basically pump the excess glucose out of the body through the kidneys without increasing or maybe even decreasing insulin levels. So they may have a similar effect to not putting the glucose into the body in the first place. Which as any dietician will tell you is highly dangerous and your brain will die.
    avatar
    graham64
    Member

    Status :
    Online
    Offline

    Male Posts : 3107
    Join date : 2014-08-10
    Location : Lancs

    Re: Diabetes drug trial needs to widen participants to understand full impact of drugs

    Post by graham64 on Tue Jul 18 2017, 22:33

    @chris c wrote:Someone described these drugs as "low carb in a pill" because they basically pump the excess glucose out of the body through the kidneys without increasing or maybe even decreasing insulin levels. So they may have a similar effect to not putting the glucose into the body in the first place. Which as any dietician will tell you is highly dangerous and your brain will die.

    They do come with some serious side effects such as ketoacidosis and increased bladder cancer risk, got to be safer than low carb though. 

    Worrying times when dietitians are actually involved in advising medics on medication doses... 

    https://twitter.com/RD_Catherine/status/887360236641767424


    _________________
    I'm a skinny T2 diagnosed 4/4/2008, a high calorie LCHF diet and one metformin a day A1c 6.2 and no complications.

    Proving the LowCarb sceptics wrong for over nine years,

    Not all cherubs are Angels  Wink nor all diabetics Bonkers  Rolling Eyes
    avatar
    chris c
    Member

    Status :
    Online
    Offline

    Posts : 3419
    Join date : 2015-07-26

    Re: Diabetes drug trial needs to widen participants to understand full impact of drugs

    Post by chris c on Wed Jul 19 2017, 22:31

    Oh that's going to be scary, now they can prescribe the harm with one hand and the cure with the other.

    Sponsored content

    Re: Diabetes drug trial needs to widen participants to understand full impact of drugs

    Post by Sponsored content


      Current date/time is Thu Dec 14 2017, 13:20